Ketorolac + Lidocaine for Pain Relief During Hysteroscopy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if adding ketorolac to lidocaine can better relieve pain during office hysteroscopies. Hysteroscopies, procedures to examine the inside of the uterus, can be uncomfortable. The trial will compare two groups: one using lidocaine with ketorolac (a nonsteroidal anti-inflammatory drug) and the other using only lidocaine. It seeks participants assigned female at birth who are scheduled for a hysteroscopy at Mount Sinai Hospital. Individuals with allergies to the medications or certain health conditions, such as kidney disease, are not eligible. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants a chance to explore new pain relief options.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a history of long-term narcotic use, you may not be eligible to participate.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that using ketorolac and lidocaine together for pain relief is generally well-tolerated. Studies have found that combining 30 mg of ketorolac with lidocaine provides better pain relief than using lidocaine alone for up to 24 hours, making the combination effective in reducing pain.
Regarding safety, this treatment is in the early stages of testing, so there is limited information about its safety in humans. However, both ketorolac and lidocaine are well-known medications. Lidocaine is often used to numb areas, and ketorolac is a common pain reliever. Both have been used safely in various medical situations.
Early studies mainly focus on the effectiveness of this combination for pain, while also closely monitoring any side effects. So far, no major safety concerns have been reported. However, since this is early testing, participants help researchers gather more information on both its effectiveness and safety.
Prospective trial participants should discuss any concerns with the study team, who can provide more detailed information tailored to individual health needs.12345Why do researchers think this study treatment might be promising?
Most treatments for pain relief during hysteroscopy typically involve the use of local anesthetics like lidocaine alone. However, combining ketorolac with lidocaine offers a unique approach. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that can enhance pain relief by targeting inflammation in addition to numbing the area. This combination could potentially provide more effective and longer-lasting pain relief compared to lidocaine by itself, which excites researchers about its potential benefits for patients undergoing hysteroscopy.
What evidence suggests that the combined ketorolac and lidocaine paracervical block might be an effective treatment for pain relief during hysteroscopy?
Research has shown that a mix of ketorolac and lidocaine can greatly reduce pain during procedures like hysteroscopy. In this trial, one group of participants will receive a paracervical block with both ketorolac and lidocaine, while another group will receive a block with just lidocaine. Specifically, one study found that this combination lessened pain during the widening of the cervix, a step in many gynecological procedures. Ketorolac is a pain reliever, while lidocaine is a numbing medicine. Together, they offer better pain relief than lidocaine alone, potentially making hysteroscopy more comfortable for patients.34678
Who Is on the Research Team?
Charles Ascher-Walsh, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for individuals experiencing abnormal uterine bleeding who are undergoing office hysteroscopy, a procedure to look inside the uterus. Participants should meet certain health criteria not specified here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a standard lidocaine paracervical block or a lidocaine plus ketorolac paracervical block during office hysteroscopy
Follow-up
Participants are monitored for pain, patient satisfaction, and adverse events immediately after the procedure and 30 minutes post-procedure
Long-term follow-up
Participants are followed for the duration of the two-year study period to assess long-term outcomes and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Combined Ketorolac and Lidocaine Paracervical Block
Combined Ketorolac and Lidocaine Paracervical Block is already approved in United States, European Union for the following indications:
- Pain management during office hysteroscopies
- Pain management during first-trimester surgical abortions
- Local anesthesia for minor surgical procedures
- Pain management during gynecologic procedures
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor